Thomas Thisted

Person

New Market, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Nicotine degrading enzyme variants
- Patent number 11,597,916
- Issue date Mar 7, 2023
- ANTIDOTE THERAPEUTICS, INC.
- Matthew W. Kalnik
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of administering a composition comprising a Tn3 scaffold an...
- Patent number 11,555,062
- Issue date Jan 17, 2023
- Viela Bio, Inc.
- Anthony Coyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nicotine-binding antibodies
- Patent number 11,440,970
- Issue date Sep 13, 2022
- ANTIDOTE THERAPEUTICS, INC.
- Matthew W. Kalnik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific m...
- Patent number 11,104,720
- Issue date Aug 31, 2021
- Viela Bio, Inc.
- Anthony Coyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha-amylase variant with altered properties
- Patent number 10,612,012
- Issue date Apr 7, 2020
- Novozymes A/S
- Allan Svendsen
- C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...
Information Patent Grant
CD40L-specific TN3-derived scaffolds and methods of use thereof
- Patent number 10,000,553
- Issue date Jun 19, 2018
- Viela Bio, Inc.
- Anthony Coyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha-amylase variant with altered properties
- Patent number 9,796,968
- Issue date Oct 24, 2017
- Novozymes A/S
- Allan Svendsen
- C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...
Information Patent Grant
Alpha-amylase variant with altered properties
- Patent number 9,670,471
- Issue date Jun 6, 2017
- Novozymes A/S
- Allan Svendsen
- C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...
Information Patent Grant
TRAIL R2-specific multimeric scaffolds
- Patent number 9,212,231
- Issue date Dec 15, 2015
- MedImmune, LLC
- Manuel Baca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha-amylase variant with altered properties
- Patent number 9,080,137
- Issue date Jul 14, 2015
- Novozymes A/S
- Allan Svendsen
- C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...

Patents Applicationslast 30 patents

Information Patent Application
NOVEL NICOTINE DEGRADING ENZYME VARIANTS
- Publication number 20230416697
- Publication date Dec 28, 2023
- Antidote Therapeutics, Inc.
- Matthew W. KALNIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-VISTA ANTIBODIES AND USES THEREOF
- Publication number 20230272082
- Publication date Aug 31, 2023
- Sensei Biotherapeutics, Inc.
- Robert PIERCE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS COMPRISING A TN3 SCAFFOLD AND METHODS OF USING THE SAME
- Publication number 20230242619
- Publication date Aug 3, 2023
- Viela Bio, Inc.
- Anthony COYLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL NICOTINE-BINDING ANTIBODIES
- Publication number 20230089068
- Publication date Mar 23, 2023
- ANTIDOTE THERAPEUTICS, INC.
- Matthew W. KALNIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR IMPROVING CIRCULATION AND TREATING CARDIOVASCULAR DISEASE
- Publication number 20220267474
- Publication date Aug 25, 2022
- ANTIDOTE THERAPEUTICS, INC.
- Matthew W. KALNIK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NUCLEIC ACIDS ENCODING A TN3 SCAFFOLD COMPRISING A CD40L-SPECIFIC M...
- Publication number 20220089688
- Publication date Mar 24, 2022
- Viela Bio, Inc.
- Anthony COYLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL NICOTINE DEGRADING ENZYME VARIANTS
- Publication number 20220031814
- Publication date Feb 3, 2022
- ANTIDOTE THERAPEUTICS, INC.
- Matthew W. KALNIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL NICOTINE-BINDING ANTIBODIES
- Publication number 20200377616
- Publication date Dec 3, 2020
- ANTIDOTE THERAPEUTICS, INC.
- Matthew W. KALNIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL NICOTINE DEGRADING ENZYME VARIANTS
- Publication number 20200224176
- Publication date Jul 16, 2020
- ANTIDOTE THERAPEUTICS, INC.
- Matthew W. KALNIK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ALPHA-AMYLASE VARIANT WITH ALTERED PROPERTIES
- Publication number 20200181593
- Publication date Jun 11, 2020
- NOVOZYMES A/S
- Allan Svendsen
- C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...
Information Patent Application
ASPARTATE BETA-HYDROXYLASE CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
- Publication number 20190345261
- Publication date Nov 14, 2019
- SENSEI BIOTHERAPEUTICS, INC.
- Michael S. Lebowitz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHA-AMYLASE VARIANT WITH ALTERED PROPERTIES
- Publication number 20190218534
- Publication date Jul 18, 2019
- NOVOZYMES A/S
- Allan Svendsen
- C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...
Information Patent Application
NICOTINE-DEGRADING ENZYMES FOR TREATING NICOTINE ADDICTION AND NICO...
- Publication number 20190015484
- Publication date Jan 17, 2019
- The Scripps Research Institute
- Kim D. JANDA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD40L-Specific TN3-Derived Scaffolds and Methods Of Use Thereof
- Publication number 20180312572
- Publication date Nov 1, 2018
- Viela Bio, Inc.
- Anthony Coyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Alpha-amylase variant with altered properties
- Publication number 20170166876
- Publication date Jun 15, 2017
- NOVOZYMES A/S
- Allan Svendsen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Alpha-amylase variant with altered properties
- Publication number 20150267183
- Publication date Sep 24, 2015
- NOVOZYMES A/S
- Allan Svendsen
- C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...
Information Patent Application
CD40L-SPECIFIC TN3-DERIVED SCAFFOLDS AND METHODS OF USE THEREOF
- Publication number 20150098955
- Publication date Apr 9, 2015
- Medlmmune, LLC
- Anthony Coyle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Alpha-amylase variant with altered properties
- Publication number 20140356924
- Publication date Dec 4, 2014
- Allan Svendsen
- C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...
Information Patent Application
Alpha-amylase variant with altered properties
- Publication number 20140080194
- Publication date Mar 20, 2014
- NOVOZYMES A/S
- Allan Svendsen
- C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...
Information Patent Application
TRAIL R2-SPECIFIC MULTIMERIC SCAFFOLDS
- Publication number 20130096058
- Publication date Apr 18, 2013
- Medimmune, LLC
- Manuel Baca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FIBRONECTIN TYPE III DOMAIN-BASED MULTIMERIC SCAFFOLDS
- Publication number 20130079280
- Publication date Mar 28, 2013
- Medlmmune, LLC
- Manuel Baca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Thomas Thisted

Person

Patents Grantslast 30 patents

Nicotine degrading enzyme variants

Methods of administering a composition comprising a Tn3 scaffold an...

Nicotine-binding antibodies

Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific m...

Alpha-amylase variant with altered properties

CD40L-specific TN3-derived scaffolds and methods of use thereof

Alpha-amylase variant with altered properties

Alpha-amylase variant with altered properties

TRAIL R2-specific multimeric scaffolds

Alpha-amylase variant with altered properties

Patents Applicationslast 30 patents

NOVEL NICOTINE DEGRADING ENZYME VARIANTS

ANTI-VISTA ANTIBODIES AND USES THEREOF

COMPOSITIONS COMPRISING A TN3 SCAFFOLD AND METHODS OF USING THE SAME

NOVEL NICOTINE-BINDING ANTIBODIES

METHODS FOR IMPROVING CIRCULATION AND TREATING CARDIOVASCULAR DISEASE

NUCLEIC ACIDS ENCODING A TN3 SCAFFOLD COMPRISING A CD40L-SPECIFIC M...

NOVEL NICOTINE DEGRADING ENZYME VARIANTS

NOVEL NICOTINE-BINDING ANTIBODIES

NOVEL NICOTINE DEGRADING ENZYME VARIANTS

ALPHA-AMYLASE VARIANT WITH ALTERED PROPERTIES

ASPARTATE BETA-HYDROXYLASE CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

ALPHA-AMYLASE VARIANT WITH ALTERED PROPERTIES

NICOTINE-DEGRADING ENZYMES FOR TREATING NICOTINE ADDICTION AND NICO...

CD40L-Specific TN3-Derived Scaffolds and Methods Of Use Thereof

Alpha-amylase variant with altered properties

Alpha-amylase variant with altered properties

CD40L-SPECIFIC TN3-DERIVED SCAFFOLDS AND METHODS OF USE THEREOF

Alpha-amylase variant with altered properties

Alpha-amylase variant with altered properties

TRAIL R2-SPECIFIC MULTIMERIC SCAFFOLDS

FIBRONECTIN TYPE III DOMAIN-BASED MULTIMERIC SCAFFOLDS